142 related articles for article (PubMed ID: 21820012)
1. The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition.
Douma TN; Kolarz A; Postma Y; Olivier B; Groenink L
Behav Brain Res; 2011 Nov; 225(1):377-81. PubMed ID: 21820012
[TBL] [Abstract][Full Text] [Related]
2. The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers.
Kelly MP; Logue SF; Dwyer JM; Beyer CE; Majchrowski H; Cai Z; Liu Z; Adedoyin A; Rosenzweig-Lipson S; Comery TA
Pharmacol Biochem Behav; 2009 Jun; 92(4):649-54. PubMed ID: 19303035
[TBL] [Abstract][Full Text] [Related]
3. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice.
Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H
Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice.
Ralph RJ; Paulus MP; Geyer MA
J Pharmacol Exp Ther; 2001 Jul; 298(1):148-55. PubMed ID: 11408536
[TBL] [Abstract][Full Text] [Related]
5. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
Arban R; Maraia G; Brackenborough K; Winyard L; Wilson A; Gerrard P; Large C
Behav Brain Res; 2005 Mar; 158(1):123-32. PubMed ID: 15680200
[TBL] [Abstract][Full Text] [Related]
7. Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion.
Martin S; van den Buuse M
Behav Brain Res; 2008 Aug; 191(2):289-93. PubMed ID: 18482774
[TBL] [Abstract][Full Text] [Related]
8. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP
Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy SS; Perez A; Koller BH; Duncan GE
Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Redrobe JP; Nielsen AN
Behav Brain Res; 2009 Mar; 198(2):481-5. PubMed ID: 19162078
[TBL] [Abstract][Full Text] [Related]
12. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats.
Kusljic S; van den Buuse M
Eur J Neurosci; 2004 Dec; 20(12):3424-32. PubMed ID: 15610175
[TBL] [Abstract][Full Text] [Related]
13. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.
Valvassori SS; Elias G; de Souza B; Petronilho F; Dal-Pizzol F; Kapczinski F; Trzesniak C; Tumas V; Dursun S; Chagas MH; Hallak JE; Zuardi AW; Quevedo J; Crippa JA
J Psychopharmacol; 2011 Feb; 25(2):274-80. PubMed ID: 19939866
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle.
Halene TB; Siegel SJ
J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599
[TBL] [Abstract][Full Text] [Related]
15. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.
Howland JG; Hannesson DK; Phillips AG
Eur J Neurosci; 2004 Nov; 20(10):2639-48. PubMed ID: 15548207
[TBL] [Abstract][Full Text] [Related]
16. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
17. Attenuated disruption of prepulse inhibition by dopaminergic stimulation after maternal deprivation and adolescent corticosterone treatment in rats.
Choy KH; van den Buuse M
Eur Neuropsychopharmacol; 2008 Jan; 18(1):1-13. PubMed ID: 17490864
[TBL] [Abstract][Full Text] [Related]
18. Nonphysical contact between cagemates alleviates the social isolation syndrome in C57BL/6 male mice.
Pietropaolo S; Feldon J; Yee BK
Behav Neurosci; 2008 Jun; 122(3):505-15. PubMed ID: 18513121
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
Ong JC; Brody SA; Large CH; Geyer MA
J Pharmacol Exp Ther; 2005 Dec; 315(3):1163-71. PubMed ID: 16123308
[TBL] [Abstract][Full Text] [Related]
20. p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.
Onogi H; Nakagawasai O; Tan-No K; Mitazaki S; Sato A; Nakaya K; Niijima F; Arai Y; Kikuchi T; Tadano T
Behav Brain Res; 2010 Dec; 214(2):349-56. PubMed ID: 20540968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
